Microdosing is nothing but taking small doses of psychedelics over the course of some days in order to experience beneficial side effects.
To be brief, microdosing comprises taking very small doses of psychedelic drugs, such as LSD (lysergic acid diethylamide) or psilocybin mushrooms, in a semi-regular schedule in order to understand reported benefits such as increased perception and creativity levels and decreased anxiety and depression.
As per researchers, the quantity of a substance like psilocybin or LSD should only be roughly one-twentieth to one-tenth the regular dose designed to “trip”. That’s 5 to 10 micrograms of LSD or 0.1 to 0.4 grams of psilocybin mushrooms. Since personal forbearances differ, the exact amount can differ person-to-person, but the ultimate is to be in an increased state of awareness, rather than a rambling state.
While psilocybin, usually known as ‘shrooms or magic mushrooms, and LSD are currently the most popular forms, Third Wave also lists cannabis, ayahuasca, mescaline, and DMT as possible substances for micro-dosing. As per recent studies, a single dose of psychedelic drugs appears to assuage the symptoms of some of the most common and tragic illnesses of the brain, including depression.
Further studies have exposed indication that psilocybin suggestively reduces anxiety in patients with life-threatening illnesses like cancer, that ketamine might have benefits as a rapid-fire antidepressant, and that MDMA (ecstasy) improves outcomes for people suffering from PTSD.
However, many argue that using these drugs is too risky, the scientific community seems to, in general, be more open to the idea that these drugs could be beneficial.